News Digest / Ticker: TXMD

Ticker: TXMD

05:19pm, Tuesday, Aug 12, 2025

TherapeuticsMD turns small Q2 profit on royalties and one-offs; Mayne litigation clouds outlook

TherapeuticsMD, Inc. (NYSE: TXMD) - Quick internal read All amounts below are in thousands of USD and per the company's Form 10-Q for the quarter ended June 30, 2025. What's happening inside: the company has fully transitioned to a royalty model after the Mayne Transaction. Operations are lean (o...

05:10pm, Tuesday, May 13, 2025

TherapeuticsMD Shifts Focus Amid Revenue Growth and Legal Challenges in Critical Financial Landscape